SANUWAVE Health, Inc. (SNWV)

Name: SANUWAVE Health, Inc. (SNWV) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001417663 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Incorporated NV
Fiscal year ends Dec 31

For the year ended 2025-12-31, SANUWAVE Health, Inc. reported revenue of $44.05M. Revenue grew 35.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $44.02M.

Key ratios (year ended 2025-12-31)

77.1%

Gross margin (computed)

11.2%

Operating margin

26.8%

Net margin

729.6%

Return on year-end equity

35.0%

Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-02

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2023-12-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31
Revenue	$44.02M	$44.05M	n/a	n/a	n/a	$32.63M	$20.40M	$16.74M	n/a	n/a	n/a
Cost of Revenue	$10.42M	$10.08M	n/a	n/a	n/a	$8.08M	$6.04M	$4.33M	n/a	n/a	n/a
Gross Profit (computed)	$33.60M	$33.97M	n/a	n/a	n/a	$24.55M	$14.36M	$12.41M	n/a	n/a	n/a
R&D Expense	$2.24M	$1.35M	n/a	n/a	n/a	$673.0K	$579.0K	$567.0K	n/a	n/a	n/a
Operating Income	$1.50M	$4.95M	n/a	n/a	n/a	$3.85M	-$540.0K	-$8.95M	n/a	n/a	n/a
Depreciation & Amortization	$1.19M	$974.0K	n/a	n/a	n/a	$788.0K	$1.03M	$952.0K	n/a	n/a	n/a
EBITDA	$2.69M	$5.92M	n/a	n/a	n/a	$4.64M	$488.0K	-$8.00M	n/a	n/a	n/a
Net Income	$15.26M	$11.81M	n/a	n/a	n/a	-$33.08M	-$25.81M	-$10.29M	n/a	n/a	n/a
EPS (Diluted)	n/a	$0.41	n/a	n/a	n/a	-$7.41	-$12.19	-$0.02	n/a	n/a	n/a
Total Assets	$36.60M	$37.34M	n/a	n/a	n/a	$30.12M	$22.42M	$19.87M	$18.78M	$17.84M	$17.01M
Total Liabilities	$33.82M	$35.72M	$43.19M	$51.84M	$51.67M	$45.91M	$65.59M	$60.88M	$54.09M	$53.38M	$55.08M
Long-Term Debt	n/a	$21.89M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shareholders' Equity	$2.79M	$1.62M	-$7.59M	-$18.80M	-$20.81M	-$15.79M	-$43.18M	-$41.01M	-$35.31M	-$35.53M	-$38.07M
Cash & Equivalents	$9.38M	$11.96M	n/a	n/a	n/a	$10.24M	$1.80M	$1.15M	$1.11M	$1.48M	$313.0K
Operating Cash Flow	$5.22M	$3.88M	n/a	n/a	n/a	$2.46M	-$4.54M	-$17.17M	n/a	n/a	n/a
Capital Expenditures	$978.0K	$1.94M	n/a	n/a	n/a	$490.0K	$0	n/a	n/a	n/a	n/a
Free Cash Flow	$4.24M	$1.93M	n/a	n/a	n/a	$1.97M	-$4.54M	n/a	n/a	n/a	n/a
Shares Outstanding	8.60M	8.59M	n/a	n/a	n/a	8.54M	3.04M	548.74M	n/a	n/a	n/a
Weighted Average Diluted Shares	n/a	9.08M	n/a	n/a	n/a	4.46M	2.12M	549.47M	n/a	n/a	n/a
EPS (Basic)	n/a	$1.38	n/a	n/a	n/a	-$7.41	-$12.19	-$0.02	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView